![](/img/cover-not-exists.png)
Phase II multicenter trial of docetaxel, epirubicin, and 5-fluorouracil (DEF) in the treatment of advanced gastric cancer: a novel, safe, and active regimen
André M. Murad, Nils G. Skare, Jéferson Vinholes, Sérgio Lago, Ricardo Pecego, Brazilian Gastric Cancer Study Group, Belo Horizonte, MG, BrazilVolume:
9
Language:
english
Pages:
7
DOI:
10.1007/s10120-006-0361-z
Date:
May, 2006
File:
PDF, 362 KB
english, 2006